← Back

Aevis Victoria SA

Aevis Victoria SA operates in the healthcare, hospitality, lifestyle, and infrastructure sectors in Switzerland through its Hospitals, Hospitality, and Real Estate segments. Its operations include private hospitals, hotels, radiology institutes, a pharmacy, a urology center, a health center, day clinics, spas, patient hotels, and golf courses. The company also provides health management programs, lifestyle coaching, and anti-aging cosmeceuticals under the Nescens brand, along with ambulance, life sciences, medical home, physiotherapy, ophthalmology, sports medicine, medical radiation, stem cells, cosmetics, parking, cleaning, sterilization, and IT-related services. Founded in 2006 and headquartered in Fribourg, Switzerland, it owns real estate properties in the healthcare and hospitality sectors and operates as a subsidiary of M.R.S.I. Medical Research, Services and Investments S.A.

Price · split & dividend adjusted
News & notes moving AEVS.SW
Aging Population

Aevis Victoria H1 2026 NAV Rises 7% as Healthcare Margins Improve

Aevis Victoria reported a net asset value of CHF26.75 per share for H1 2026, up nearly 7% year-over-year and 2.3% versus the prior year-end level, while the discount to NAV remained above 50%, which management described as unprecedented in the group's history. Within the healthcare segment, Swiss Medical Network's EBITDA margin improved from 18.6% to 21.6%, and ambulatory services turned EBITDA-positive for the first time, with its margin rising from 7.1% to 11.8%. The company set a healthcare EBITDA margin target of 23% with organic growth of 2% to 3% per year, noting mature hospitals representing over 50% of the portfolio can reach more than 25% to 26% EBITDA margin while ramp-up hospitals sit at 10% to 20%. Interest expenses declined 43% year-over-year, consolidated net debt stood at CHF846 million with the bulk under Swiss Hotel Property, Swiss Medical Network's net debt-to-EBITDA was approximately 2.2x to 2.3x, and loan-to-value for the real estate business fell to 45%. Chief Financial Officer Michel Keusch cited three catalysts to narrow the discount to NAV: a next phase of value crystallization through selling stakes to strategic shareholders, including the officially announced search for strategic investors in Swiss Medical Network; enhanced investor relations with more roadshows, a Capital Markets Day and greater financial transparency; and a near-quintupling of average daily liquidity over the past two years.
GuruFocus·1dRead more →